On 21 March 2023, Tanzania’s Ministry of Health officially declared an outbreak of Marburg virus disease, turning the nation from a Marburg‑free status to an active outbreak zone in a single day. The virus, a severe haemorrhagic fever, has never before been recorded in the country.
Marburg virus is highly contagious and can be fatal. Historical outbreaks have shown case‑fatality rates ranging from 24 % to 88 %, depending on the viral strain and the level of medical care available. Transmission occurs through direct contact with infected bodily fluids or through surfaces contaminated with those fluids.
At present, there is no licensed vaccine and no specific antiviral medication; treatment is limited to supportive care such as rehydration, oxygen therapy and management of complications. The appearance of Marburg in Tanzania presents a unique challenge for a health system that has never managed this pathogen.
Existing protocols for isolation, safe burial practices and contact tracing must be created or heavily adapted. Health‑care workers need rapid training on the correct use of personal protective equipment, because a single lapse could initiate a new chain of infection. Prompt reporting by the Ministry of Health is a crucial first step.
Early notification enables international agencies to mobilise assistance, allows neighbouring states to heighten border surveillance, and gives Tanzanian officials a window to trace contacts before the virus spreads unnoticed. Nevertheless, timely reporting alone will not contain the disease.
Effective containment depends on a functional response framework, which is already under pressure. Early symptoms of Marburg—fever, headache and muscle aches—mirror common illnesses such as malaria and typhoid that are endemic in East Africa. By the third day, patients may develop vomiting, diarrhoea and abdominal pain; hemorrhagic signs such as bleeding from the gums, nose or gastrointestinal tract can appear between days five and seven. Death can occur within eight to nine days of symptom onset.
The similarity to other febrile diseases raises the risk of misdiagnosis, potentially leading to infected individuals being sent home with antimalarial drugs and exposing families. The full scale of the outbreak remains uncertain.
Undetected cases could indicate that the virus has already moved beyond the initial cluster. Health officials are monitoring hospitals and clinics for unusual patterns of fever and bleeding, while simultaneously identifying and following up with anyone who has been in contact with confirmed patients. Each contact is required to be observed for up to 21 days, the maximum incubation period for Marburg.
Tanzania does possess experience handling other epidemics, including cholera and dengue, but Marburg demands a higher level of biosafety. Facilities may need to overcome shortages of reliable water, electricity, gloves and masks to achieve the strict infection‑control standards required for this disease.
The international community is watching closely. The World Health Organization has been alerted, and regional partners are reportedly on standby to provide assistance if needed. The stakes are clear.
If containment measures succeed quickly, the outbreak may be limited to a small number of cases. Failure to maintain surveillance and infection‑control could allow the virus to spread to urban centres, refugee camps or cross‑border transport hubs.
Tanzania shares borders with eight countries, including Kenya, Uganda and the Democratic Republic of the Congo, each with its own vulnerable health infrastructure. For now, Tanzanian authorities are concentrating on isolating patients, tracing contacts and improving hygiene practices in health facilities. The coming days will test whether these actions are sufficient to halt a virus that spreads rapidly.
The response must keep pace with the speed of Marburg’s progression.
